ANDA 40125, held by Epic Pharma LLC. Thioridazine Hydrochloride.
As of Nov 16, 2026, ANDA 40125 (Thioridazine Hydrochloride), held by Epic Pharma LLC, was first approved by FDA on Aug 16, 1996, with 3 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 16, 1996 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Thioridazine Hydrochloride30MG/ML · concentrate;oral | Thioridazine Hydrochloride | Discontinued |
| Jan 22, 2025 | Supplement 3Labeling · Standard review | Approved | None posted |
| Feb 23, 2017 | Supplement 2Labeling · Standard review | Approved | None posted |
| Dec 3, 2010 | Supplement 1Labeling | Approved | None posted |
| Aug 16, 1996 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters